Skip to main content Back to Top

Standardize 4 Safety - Past, Present, and Future of Safer Care

Broadcast Date: May 23, 2022


Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

Safety is at the forefront of all processes in the pharmacy department. ASHP has been a champion of safety since the organization originated more than 75 years ago.

ASHP received funding from the Food and Drug Administration’s (FDA) Safe Use Initiative to develop and implement national standardized concentrations for IV and oral liquid medications. This is the first national inter-professional (physicians, pharmacists, nurses) initiative to standardize medication concentrations with the goal of reducing prescribing, dispensing, and medication errors for patients of all ages in settings ranging from hospital to home. This outstanding program, called Standardize 4 Safety, will have substantial downstream effects on safety, cost, efficiency, and error-reduction.

Standardization will result in consolidated/converged product demand from hospitals, and more instances of ready-for-use drug preparations from manufacturers, simpler drug libraries, improvements to automatic drug recognition by infusion pumps, and improved clinical information system data exchange.


Deborah PaskoDeborah (Deb) Pasko, BSPharm, PharmD, MHA is a Data Solutions Architect and Program Director at Parexel International. Dr. Pasko received her BSPharm degree from Ohio Northern University, PharmD degree from Idaho State University, and her Masters of Health Administration degree from Walden University. She completed a fellowship in Nephrology and Critical Care at the University of Michigan – College of Pharmacy in Ann Arbor, MI.

Rita JewRita K. Jew, PharmD, MBA, BCPPS, FASHP is President at the Institute for Safe Medication Practice (ISMP), Plymouth Meeting, Pennsylvania. Prior to ISMP, Dr. Jew held various leadership positions including Director of Pharmacy at UCSF Health, Executive Director of Pharmacy & Clinical Nutrition Services at CHOC Children’s and Clinical Manager at Children’s Hospital of Philadelphia. Dr. Jew received her PharmD from University of California at San Francisco, completed an ASHP-Accredited Residency in Clinical Pharmacy at Thomas Jefferson University Hospital and received her MBA from the Wharton School, University of Pennsylvania. She is a Board-Certified Pediatric Pharmacy Specialist (BCPPS).

Mary Ann KliethermesMary Ann Kliethermes, PharmD, FASHP received a BS in pharmacy from the University of Michigan (1977) and Doctor of Pharmacy from the Philadelphia College of Pharmacy and Science (1981). Her 45 year clinical practice includes hospital, home infusion, ambulatory practice and academia. Currently she is Director of Medication Safety and Quality at ASHP. Her expertise is pharmacist reimbursement, medication optimization, safety and quality, and new healthcare models and payment systems.


Relevant Financial Relationship Disclosures

No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.

As defined by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company. 


More in this series

Standardize 4 Safety: How Did It Start and Where Is It Going?

A Plea for Standardization

Standardize 4 Safety: Taking Aim at Strategies for Adoption


The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Provided by ASHP
Sponsored by Baxter Healthcare Corporation